CompletedNot Applicable

Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab

Italy5 participantsStarted 2016-01-01

Plain-language summary

This study evaluates the retinal and vascular features in patients affected by Coats disease under the effects of Ranibizumab intravitreal injections using optical coherence tomography and optical coherence tomography angiography

Who can participate

Age range19 Years – 30 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age older than 18 years * diagnosis of Coats disease * treatment-naïve with Ranibizumab * absence of other vitreoretinal and vascular retinal diseases * absence of diabetes Exclusion Criteria: * age younger than 18 years * No diagnosis of Coats disease * previous treatments with Ranibizumab * presence of vitreoretinal and vascular retinal diseases * presence of diabetes

What they're measuring

Study of retinal and vascular features in Coats disease after intravitreal injections of Ranibizumab

Timeframe: Three months

Study of retinal and vascular features in Coats disease after intravitreal injections of Ranibizumab

Timeframe: Three months

Trial details

NCT IDNCT04310631

SponsorFederico II University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12-31

View on ClinicalTrials.gov More Coats Disease trials